购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Antibacterial
    (1)
  • Carbonic Anhydrase
    (1)
  • Cholinesterase (ChE)
    (1)
  • EGFR
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (5)
  • 5日内发货
    (2)
  • 35日内发货
    (2)
  • 6-8周
    (2)
筛选
搜索结果
TargetMol产品目录中 "

nm 283

"的结果
  • 抑制剂&激动剂
    15
    TargetMol | Inhibitors_Agonists
  • 多肽产品
    1
    TargetMol | Peptide_Products
  • Valopicitabine
    NM283
    T13281640281-90-9
    Valopicitabine is an effective prodrug of the effective anti-HCV drug 2'-C-methylcytidine and can be used as a promising antiviral drug for the study of chronic HCV infection.
    • ¥ 19900
    10-14周
    规格
    数量
  • Valopicitabine dihydrochloride
    NM283 dihydrochloride, Valopicitabine HCl, NM-283 dihydrochloride, NMC283, NMC-283
    T29094640725-71-9
    Valopicitabine, a NS5B inhibitor, is used potentially for the treatment of HCV infection.
    • ¥ 2400
    5日内发货
    规格
    数量
  • SR-318
    T129972413286-32-3In house
    SR-318 是p38 MAPK 的选择性抑制剂,对 p38α,p38β 和 p38α β 的IC50分别为 5 nM,32 nM 和 6.11 μM。它有效抑制全血中TNF-α的释放,IC50为 283 nM。它显示出抗癌和抗炎活性。
    • ¥ 238
    In stock
    规格
    数量
  • SR-3306
    T169271128096-91-2In house
    SR-3306 一种脑渗透性和选择性泛 JNK (JNK1 2 3) 抑制剂, IC50值分别为67 nM283 nM,159 nM,并可减少食物摄入量和体重。
    • ¥ 456
    In stock
    规格
    数量
    TargetMol | Inhibitor Sale
  • UbcH5c-IN-1
    T132422123480-72-6
    UbcH5c-IN-1 is a selective small-molecule Ubiquitin-conjugating enzyme UbcH5c inhibitor (Kd: 283 nM for E2 UbcH5c-IN-1 by covalent binding with Cys85).
    • ¥ 10600
    6-8周
    规格
    数量
  • β-Glucuronidase-IN-1
    β葡萄糖醛酸酶-IN-1
    T13477484006-66-8
    β-Glucuronidase-IN-1 是一种 E. coli β-葡萄糖醛酸酶 (β-glucuronidase) 抑制剂,对 E. coli β-葡萄糖醛酸酶的 IC50 和 Ki 值分别为 283 nM 和 164 nM,具有强效性,选择性,非竞争性和具有口服活性。
    • ¥ 378
    In stock
    规格
    数量
  • LLY-283
    T157672040291-27-6
    LLY-283 是一种有效的,选择性的,可口服的蛋白精氨酸甲基转移酶 5 (PRMT5) 抑制剂,对 PRMT5:MEP50 复合物的作用很强,IC50 和 Kd 值分别为 22 nM 和 6 nM,具有抗肿瘤活性。
    • ¥ 362
    In stock
    规格
    数量
  • L 888607
    T15828860033-06-3
    L 888607 is an effective and selective CRTH2 agonist (Ki: 0.8 nM).
    • ¥ 2220
    5日内发货
    规格
    数量
  • AChE/hCA I-IN-1
    T204128155140-19-5
    AChE hCA I-IN-1 (Compound L3) 是一种针对乙酰胆碱酯酶 (AChE) 和碳酸酐酶 (CA) 的抑制剂,其抑制乙酰胆碱酯酶、hCA I 和 hCA II 的 IC50 值分别为 302 nM、265 nM283 nM
    • 待询
    10-14周
    规格
    数量
  • Lifirafenib
    BGB-283, Beigene-283
    T222721446090-79-4
    Lifirafenib (Beigene-283) 是新型高效的Raf 激酶和EGFR 抑制剂,对重组BRafV600E 和EGFR 的IC50值分别为 23 和 29 nM
    • ¥ 237
    In stock
    规格
    数量
  • 9(Z),11(E)-Conjugated Linoleic Acid (sodium salt)
    T35854756499-04-4
    9(Z),11(E)-Conjugated linoleic acid is an isomer of linoleic acid that has been found in beef and milk fat.1It binds to peroxisome proliferator-activated receptor α (PPARα; IC50= 140 nM) and activates the receptor in a reporter assay using COS-1 cells expressing mouse PPARα when used at a concentration of 100 μM.29(Z),11(E)-Conjugated linoleic acid inhibits TNF-α-inducedGLUT4expression and increases insulin-stimulated glucose transport in 3T3-L1 adipocytes.3Dietary administration of 9(Z)11(E)-conjugated linoleic acid reduces serum fasting glucose, insulin, and triglyceride levels and decreases white adipose tissue macrophage infiltration inob obmice. It also increases body weight gain and body fat in weanling mice.4[Matreya, LLC. Catalog No. 1278] 1.Shultz, T.D., Chew, B.P., Seaman, W.R., et al.Inhibitory effect of conjugated dienoic derivatives of linoleic acid and β-carotene on the in vitro growth of human cancer cellsCancer Lett.63(2)125-133(1992) 2.Moya-Camarena, S.Y., Heuvel, J.P.V., Blanchard, S.G., et al.Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARαJ. Lipid Res.40(8)1426-1433(1999) 3.Moloney, F., Toomey, S., Noone, E., et al.Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissueDiabetes56(3)574-582(2007) 4.Pariza, M.W., Park, Y., and Cook, M.E.The biologically active isomers of conjugated linoleic acidProg. Lipid Res.40(4)283-298(2001)
    • 待估
    35日内发货
    规格
    数量
  • PACAP (6-27) (human, chicken, mouse, ovine, porcine, rat) (trifluoroacetate salt)
    T36427
    Pituitary adenylate cyclase-activating peptide (PACAP) (6-27) is a PACAP receptor antagonist with IC50 values of 1,500, 600, and 300 nM, respectively, for rat PAC1, rat VPAC1, and human VPAC2 recombinant receptors expressed in CHO cells. It binds to PACAP receptors on SH-SY5Y and SK-N-MC human neuroblastoma and T47D human breast cancer cells (IC50s = 24.5, 106, and 105 nM, respectively) and inhibits cAMP accumulation induced by PACAP (1-38) (Kis = 457, 102, and 283 nM, respectively, in SH-SY5Y, SK-N-MC, and T47D cells). In vivo, in newborn pigs, PACAP (6-27) (10 μM) inhibits vasodilation of pial arterioles induced by PACAP (1-27) and PACAP (1-38) . It also inhibits PACAP (1-27)-stimulated increases in plasma insulin and glucagon levels and pancreatic venous blood flow in dogs when administered locally to the pancreas at a dose of 500 μg.
    • 待估
    35日内发货
    规格
    数量
  • Axl-IN-5
    T638172642224-24-4
    Axl-IN-5 (compound 1) 是 AXL 抑制剂 (IC50: 283 nM),表现出抗癌活性。
    • ¥ 10600
    6-8周
    规格
    数量
  • DGKα-IN-3
    T798222648418-86-2
    DGKα-IN-3 作为DGKα抑制剂,具有283 nM的IC50。该化合物能够通过提升T细胞的增殖及功能,显著增强抗PD-1治疗的抗肿瘤效果。因此,DGKα-IN-2在肿瘤和免疫学领域研究中显示出了潜在的应用价值。
    • 待询
    8-10周
    规格
    数量
  • Lifirafenib maleate
    BGB-283 maleate
    T868101854985-74-2
    Lifirafenib (BGB-283) maleate 是一种高效的Raf激酶和EGFR抑制剂,对重组BRafV600E和EGFR的IC50值分别为23 nM和29 nM
    • 待询
    10-14周
    规格
    数量
没有更多数据了